|
Matching, Outcomes and Costs in Substance Abuse/Psychiatric Treatment Clinical Trials Info presented on Clinical Trials Search is not intended to be a substitute for certified medical advice, visits or professional assistance using a real physician. We are not physicians. Always consult your dr. about Matching, Outcomes and Costs in Substance Abuse/Psychiatric Treatment conditions. Clinical Trials Search.org is a site dedicated to listing clinical research studies in human subjects. Matching, Outcomes and Costs in Substance Abuse/Psychiatric Treatment Clinical research trials and Matching, Outcomes and Costs in Substance Abuse/Psychiatric Treatment health trials happen in many of localities throughout the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically measure the effectualness of new drugs. The function of the studies / projects is to resolve particular human medical questions. Clinical trials are a popular manner for mDs, government agencies, and private sector corporations to discover remedies for all varieties of circumstances, like Matching, Outcomes and Costs in Substance Abuse/Psychiatric Treatment. Matching, Outcomes and Costs in Substance Abuse/Psychiatric Treatment Clinical Trials and other clinical trials allow volunteers to obtain healthcare treatment options before they are available to the masses. Some times the participants undergo professional assistance for free of charge, and occasionally they are paid for their time. Sometimes there is a cost for a Matching, Outcomes and Costs in Substance Abuse/Psychiatric Treatment clinical trial. Human subjects often get the best healthcare available for their Matching, Outcomes and Costs in Substance Abuse/Psychiatric Treatment condition. Dangers are a reality, however, and may include additional or frequent mD visits, healthcare dangers (potentially life-jeopardising), and/or the treatment being ineffectual. Trials are federally governed with rigorous guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "M" Clinical Trials Conditions > Matching, Outcomes and Costs in Substance Abuse/Psychiatric Treatment Matching, Outcomes and Costs in Substance Abuse/Psychiatric Treatment
Matching, Outcomes and Costs in Substance Abuse/Psychiatric Treatment
For Condition: Diagnosis, Dual (Psychiatry),Substance-Related Disorders
Status: Completed
Sponsor(s): Department of Veterans Affairs , Department of Veterans Affairs Health Services Research and Development Service
Synopsis: This project is providing information on current efforts to transfer mental health care away from hospitals and to match patients to different types of community care. Its ultimate goal is to improve the quality of care and reduce treatment costs for veterans with substance abuse and psychiatric problems. This project is evaluating a patient-treatment matching strategy to improve hospital- and community-based residential treatment for substance abuse patients with psychiatric disorders. Its immediate objective is to examine whether the matching strategy results in more effective and cost-effective treatment in VA programs. We hypothesize that patients with severe clinical and functional problems will have better outcomes when they are matched to service-intensive programs; patients with moderate problems will have better outcomes when they are matched to programs having a lower intensity of services. For both patient groups, community-based treatment should prove to be more cost-effective than hospital-based treatment. The project is utilizing a stratified randomized design. We have paired each of three VA hospital-based programs that treat dual diagnosis patients and are high on intensity with a nearby high-intensity community residential facility (CRF) that contracts with the VA. We have also paired four VA hospital and four community programs that are low on intensity. Veterans who apply for substance abuse treatment at VA facilities are randomly assigned to either the VA hospital or community program. Patient assessments are conducted at intake (to date, N=224), discharge, and 4- and 12-month follow-ups. Primary outcomes are patients? severity of substance abuse and psychiatric problems. Secondary outcomes are patients? functional status and their VA and non-VA health care utilization and its costs.
Details:
Eligibility:
Study Type: Interventional, Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: Patients must be entering a VA inpatient substance abuse or psychiatric treatment program and be clinically judged as appropriate for inpatient or community residential care.
Total Enrollment: 236
Location and Contact Information:
VA Palo Alto Health Care System
Palo Alto, California, 94304-1207
United States
Edward Hines, Jr. VA Hospital
Hines, Illinois, 60141-5000
United States
Additional Information:
Study ID Numbers: IIR 95-011;
Study Start Date: October 1997
Record last reviewed: November 2000
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00012727
Other Substance-Related Disorders Studies:
1. Matching, Outcomes and Costs in Substance Abuse/Psychiatric Treatment
Related Studies:
Other Substance-Related Disorders Clinical Trials
Other Illinois Clinical Trials
Other Hines Clinical Trials
Matching, Outcomes and Costs in Substance Abuse/Psychiatric Treatment
|
|
|
|
|
|
|
|